Master Protocol of Two Randomized, Double-blind, Placebo Controlled, Multi-center, Parallel-group Studies of Dupilumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite the Use of H1 Antihistamine Treatment in Patients naive to Omalizumab and in Patients Who Are Intolerant or Incomplete Responders to Omalizumab
ClinicalTrials.gov NCT04180488
Research payments
$730,227
Through program year 2025, $730,227 in research payments was reported against Master Protocol of Two Randomized, Double-blind, Placebo Controlled, Multi-center, Parallel-group Studies of Dupilumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite the Use of H1 Antihistamine Treatment in Patients naive to Omalizumab and in Patients Who Are Intolerant or Incomplete Responders to Omalizumab, across 206 payments, paid by Sanofi US Services Inc..
- Paid by
- Sanofi US Services Inc.
- ClinicalTrials.gov
- NCT04180488
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $22,375 | 5 |
| 2024 | Research | $157,027 | 32 |
| 2023 | Research | $56,859 | 12 |
| 2022 | Research | $159,678 | 40 |
| 2021 | Research | $319,256 | 113 |
| 2020 | Research | $15,032 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Sarbjit Saini Baltimore, MD Named on 19 payments
- Gary Gross Dallas, TX Named on 19 payments
- Jeffrey Tillinghast Saint Louis, MO Named on 19 payments
- Lee Clore Owensboro, KY Named on 18 payments
- Roopen Patel Charlotte, NC Named on 13 payments
- John Ramey North Charleston, SC Named on 12 payments
- Thomas Casale Tampa, FL Named on 10 payments
- John Niven Miami Beach, FL Named on 7 payments
- Jonathan Bernstein Cincinnati, OH Named on 7 payments
- Michael Palumbo Pittsburgh, PA Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.